GALNT10

Across TCGA pan-cancer cohorts, GALNT10 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GALNT10’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where GALNT10 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types GALNT10 is over-expressed in tumor, although a few such as LSCC show the opposite, repressed pattern.

LUAD, PDAC, and LSCC are the cancer types where GALNT10 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GALNT10 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	+0.945	<.001	9	view →
PDAC	All	II,III,IV	+0.536	<.001	6	view →
LSCC	All	II,III,IV	−0.203	.001	4	view →
HNSC	Male	III,IV	+0.285	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

GALNT10–LUAD

Open the LUAD breakdown →